Roche Pharma (Schweiz) AG
🇨🇭Switzerland
Clinical Trials
2
Active:2
Completed:0
Trial Phases
0 Phases
Drug Approvals
55
NMPA:55
Drug Approvals
Trastuzumab Emtansine for Injection
- Product Name
- 赫赛莱
- Approval Number
- 国药准字SJ20200002
- Approval Date
- Nov 7, 2024
NMPA
Trastuzumab Emtansine for Injection
- Product Name
- 赫赛莱
- Approval Number
- 国药准字SJ20200003
- Approval Date
- Nov 7, 2024
NMPA
Rituximab Injection (Subcutaneous Injection)
- Product Name
- 利妥昔单抗注射液(皮下注射)
- Approval Number
- 国药准字SJ20240013
- Approval Date
- Apr 2, 2024
NMPA
Baloxavir Marboxil for Suspension
- Product Name
- 玛巴洛沙韦干混悬剂
- Approval Number
- 国药准字HJ20230153
- Approval Date
- Dec 29, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found